However, a study mined the expression of thirteen LRPs from The Cancer Genome Atlas (TCGA) in ten common solid malignancies and found that LRP10 was significantly associated with decreased patient survival in three different malignancies: hepatocellular carcinoma, lung adenocarcinoma, and pancreatic adenocarcinoma (Gonias et al., 2017). Here, LRP10 is linked to pancreatic adenocarcinoma.